Autopsy report · NCT04941378

OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer

“Due to sponsor request”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Abramson Cancer Center at Penn Medicine

Sponsor type

University, hospital or other

Conditions

Ovarian Cancer

Interventions

OTL38; intraoperative imaging camera system

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer
  “requested by sponsor” (88% match in meaning)
• Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS
  “Due to sponsor decision” (87% match in meaning)
• Effects of Metreleptin in Type 1 Diabetes Mellitus
  “Sponsor request” (86% match in meaning)
• A Study to Evaluate ART101 in Adult Participants With Hypertension
  “At Sponsor's Request” (82% match in meaning)
• Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations
  “Due to the sponsor circumstances and external reasons” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.